Company Monitoring Page for AbbVie

latest headlines for company on cafepharma

AbbVie led the way in paying doctors to pitch its drugs last year
Axios
Mon, 07/15/24 - 09:57 am
Tags:
AbbVie, physician payments
AbbVie Submits Applications for Rinvoq for Giant Cell Arteritis
Managed Healthcare Executive
Sun, 07/14/24 - 10:12 pm
Tags:
AbbVie, Rinvoq, FDA, EMA, giant cell arteritis
AbbVie’s Humira continues to lose market share as biosimilars gain ground
BioSpace
Fri, 07/12/24 - 11:35 am
Tags:
AbbVie, Humira, biosimilars
AbbVie asks Supreme Court to uphold attorney-client privilege in AndroGel lawsuit
Fierce Pharma
Thu, 07/11/24 - 11:02 pm
Tags:
AbbVie, Androgel, legal, Supreme Court, generics
Don’t call it a comeback: Biotech’s CNS resurgence forges Big Pharma connections
Pharma Voice
Fri, 06/28/24 - 11:17 am
Tags:
Big Pharma, Neuroscience, Prothena Biosciences, Biogen, Eisai, Pfizer, AbbVie, Eli Lilly, Bristol Myers Squibb
AbbVie sweeps up inflammatory-focused Celsius for $250M cash in summer heat wave
Fierce Biotech
Thu, 06/27/24 - 11:27 am
Tags:
AbbVie, M&A, Celsius Therapeutics
AbbVie, Genmab Secure FDA Label Expansion for Epkinly in Follicular Lymphoma
BioSpace
Thu, 06/27/24 - 11:25 am
Tags:
FDA, AbbVie, Genmab, Epkinly, relapsed or refractory follicular lymphoma
FDA Again Hits AbbVie Parkinson’s Treatment With Complete Response Letter
BioSpace
Tue, 06/25/24 - 11:29 am
Tags:
AbbVie, Parkinson's Disease, FDA, ABBV-951
FDA approves Abbvie's Skyrizi for ulcerative colitis
PR Newswire
Tue, 06/18/24 - 07:56 pm
Tags:
AbbVie, FDA, Skyrizi, ulcerative colitis
AbbVie inks immune disorder drug licensing deal with China's FutureGen
Reuters
Thu, 06/13/24 - 11:07 am
Tags:
AbbVie, FutureGen, China, IBD
AbbVie's tight grip on Humira market raises concerns about biosimilars
Reuters
Fri, 06/7/24 - 11:32 am
Tags:
AbbVie, Humira, biosimilars
After AbbVie's ImmunoGen buy, Elahere posts midstage trial win in ovarian cancer subtype
Fierce Pharma
Thu, 06/6/24 - 09:13 pm
Tags:
AbbVie, antibody-drug conjugates, Elahere, Immunogen
AbbVie treats first subject in Phase III multiple myeloma drug trial
Clinical Trials Arena
Thu, 06/6/24 - 11:31 am
Tags:
AbbVie, clinical trials, ABBV-383, Multiple Myeloma
Top ten biopharma R&D deals of 2024
Nature
Wed, 06/5/24 - 11:24 am
Tags:
R&D, Novartis, Argo Biopharmaceutical, Roche, MOMA Therapeutics, Boehringer Ingelheim, Suzhou Ribo Life Science, Eli Lilly, Isomorphic Labs, Merus, Gilead Sciences, Novo Nordisk, Neomorph, AbbVie, Umoja Biopharma, Merck KGaA, Caris Life Sciences, Voyager Therapeutics
ASCO 2024: AbbVie flexes early success of ADC pipeline in solid tumours
Clinical Trials Arena
Mon, 06/3/24 - 12:06 pm
Tags:
ASCO 2024, AbbVie, antibody-drug conjugates, Teliso-V, ABBV-400, ABBV-706, solid tumors
Big Pharma’s most improved drugs: a new generation of blockbusters
Pharma Voice
Tue, 05/14/24 - 11:34 am
Tags:
Big Pharma, Eli Lilly, Mounjaro, Novo Nordisk, Wegovy, JNJ, Tecvayli, Merck, Vaxneuvance, AbbVie, Qulipta, AstraZeneca, Saphnelo, Novartis, Leqvio, Roche, Genentech, Vabysmo, Amgen, Evenity, Pfizer, Vyndaqel
AbbVie joins psychedelic push, inks $2B+ next-gen neuro deal with Gilgamesh
Fierce Biotech
Mon, 05/13/24 - 10:21 pm
Tags:
AbbVie, psychedelics, Gilgamesh Pharmaceuticals, R&D
The 25 Most Popular Drugs by U.S. Spending
AARP
Fri, 05/10/24 - 11:33 am
Tags:
prescription spending, Ozempic, Rybelsus, Wegovy, Eliquis, Humira, Novo Nordisk, AbbVie
Teva Pharm to launch Humira biosimilar as Q1 profit misses estimates
Reuters
Wed, 05/8/24 - 10:58 pm
Tags:
Teva Pharmaceutical, earnings, biosimilars, AbbVie, Humira
Sandoz delivers 6% sales growth with Humira biosimilar leading the charge
Fierce Pharma
Tue, 05/7/24 - 06:30 pm
Tags:
Sandoz, earnings, biosimilars, AbbVie, Humira

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.